Table 3.
Periprocedural outcomes.
| Postprocedural Outcomes n (%); m (SD) |
Patients Undergoing TA Aortic Procedures n = 154 |
|---|---|
| Periprocedural mortality | 3 (1.9) |
| Bleeding | |
| Type 1 | 2 (1.3) |
| Type 2 | 2 (1.3) |
| Type 3 | 1 (0.6) |
| Type 4 | - |
| Vascular complications | |
| Major | - |
| Minor | 7 (4.5) |
| Access-related non-vascular complications | |
| Major | - |
| Minor | 1 (0.6) |
| Cardiac tamponade requiring surgical revision | 1 (0.6) |
| Valve malposition | - |
| Valve thrombosis | 1 (0.5) |
| AKI stage 3 | 3 (1.9) |
| New dialysis | - |
| Peak of creatinine, umol/L | 119.8 (75.6) |
| Neurological events | |
| Stroke | 1 (0.6) |
| TIA | - |
| New onset atrial fibrillation | 42 (27.3) |
| PM implantation | 3 (1.9) |
| Coronary obstruction | 3 (1.9) |
| Periprocedural myocardial infarction | 3 (1.9) |
| Length of ICU stay, days | 1.61 (1.3) |
| Prolongued ventilation (>24 h) | 3 (1.9) |
| Pneumonia | 5 (3.2) |
| Wound infection | 2 (1.3) |
| LVEF, % | 55.3 (8.4) |
| NYHA class at discharge | |
| I | 71 (46.1) |
| II | 73 (47.4) |
| III | 7 (4.5) |
| IV | - |
Legend: AKI, Acute Kidney Injury; TIA, Transient Ischemic Attack; PM, Pacemaker; ICU, Intensive Care Unit; LVEF: Left Ventricular Ejection Fraction; NYHA, New York Heart Association.